Neoatricon
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neoatricon, covering 2025-07-04 to 2025-07-04. Get the full timeline:
Most recent: EMA Authorised: Neoatricon (dopamine hydrochloride;Dopamine) — BrePco Biopharma Limited